AtomVie opens $160m radiopharmaceutical manufacturing facility in Ontario
The site supports low-to-high throughput production and increases AtomVie's manufacturing capacity more than tenfold.
Drug Development
FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer
Superluminal Medicines secures $60m to advance rare obesity therapy
Médunik and Biocodex sign exclusive agreement for Diacomit in Canada
Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule
Novartis signs $3.2bn drug delivery deal with Alteogen
Ono Pharmaceutical joins forces with Aitia for drug discovery in neurology
Takeda and Weave Bio collaborate on AI-driven automation in drug development
